During the recent session, Quantum BioPharma Ltd (NASDAQ:QNTM)’s traded shares were 0.56 million, with the beta value of the company hitting 0.15. At the last check today, the stock’s price was $8.78, reflecting an intraday gain of 26.29% or $1.83. The 52-week high for the QNTM share is $46.87, that puts it down -433.83 from that peak though still a striking 69.25% gain since the share price plummeted to a 52-week low of $2.70. The company’s market capitalization is $16.85M, and the average intraday trading volume over the past 10 days was 1.22 million shares, and the average trade volume was 2.60 million shares over the past three months.

Quantum BioPharma Ltd (NASDAQ:QNTM) trade information

Quantum BioPharma Ltd (QNTM) registered a 26.29% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 26.29% in intraday trading to $8.78, hitting a weekly high. The stock’s 5-day price performance is 30.03%, and it has moved by 52.11% in 30 days. Based on these gigs, the overall price performance for the year is -79.86%. The short interest in Quantum BioPharma Ltd (NASDAQ:QNTM) is 47433.0 shares and it means that shorts have 0.25 day(s) to cover.

QNTM Dividends

Quantum BioPharma Ltd is due to release its next quarterly earnings on 2024-Nov-10. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Quantum BioPharma Ltd (NASDAQ:QNTM)’s Major holders

Quantum BioPharma Ltd insiders own 11.46% of total outstanding shares while institutional holders control 14.84%, with the float percentage being 16.76%.

Data provided on Feb 28, 2025 indicates that AdvisorShares Trust-AdvisorShares Psychedelics ETF owns about 74.99 shares. This amounts to just over 3.26 percent of the company’s overall shares, with a $0.63 million market value.